Labo EuromedisXPAR:ALEMG 61 Market Cap is €13.94 Mil as of Jul. 13, 2026. GuruFocus rates XPAR:ALEMG with a GF Score™ of 61/100 and a GF Value™ of €4.48 (Fairly Valued). The stock has 6 warning signs investors should review. Among 120 Medical Distribution companies, Labo Euromedis ranks worse than 81.67% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Labo Euromedis's share price for the quarter that ended in Dec. 2025 was €3.92. Labo Euromedis's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 2.86 Mil. Therefore, Labo Euromedis's market cap for the quarter that ended in Dec. 2025 was €11.20 Mil.
Labo Euromedis's quarterly market cap
increased
from Dec. 2024 (€12.51 Mil) to Jun. 2025 (€12.54 Mil) but then
declined
from Jun. 2025 (€12.54 Mil) to Dec. 2025 (€11.20 Mil).
Labo Euromedis's annual market cap
declined
from Dec. 2023 (€15.16 Mil) to Dec. 2024 (€12.51 Mil) and
declined
from Dec. 2024 (€12.51 Mil) to Dec. 2025 (€11.20 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Labo Euromedis's Enterprise Value for Today is €3.37 Mil.
Labo Euromedis (XPAR:ALEMG) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Labo Euromedis Market Cap Related Terms
Labo Euromedis Market Cap Historical Data
* Premium members only.
The historical data trend for Labo Euromedis's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALEMG vs MCK, CAH, COR: Market Cap Comparison
For the Medical Distribution subindustry, Labo Euromedis's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labo Euromedis Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Labo Euromedis's Market Cap distribution charts can be found below:
* The bar in red indicates where Labo Euromedis's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Labo Euromedis's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labo Euromedis (XPAR:ALEMG) has a Market Cap of €13.94 Mil as of Jul. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Labo Euromedis and its competitors. According to the industry distribution chart, Labo Euromedis ranks #98 out of 120 companies in the Medical Distribution industry, placing it in the top 81.7%.
Is Labo Euromedis' Market Cap too high?
Labo Euromedis' current Market Cap is €13.94 Mil. Based on the distribution chart, Labo Euromedis ranks #98 out of 120 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, Labo Euromedis has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labo Euromedis' Market Cap compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Labo Euromedis ranks #98 out of 120 companies for Market Cap. This places Labo Euromedis in the lower half of its industry. The industry median Market Cap is 146.94. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 146.94, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Labo Euromedis and its competitors. For the Medical Distribution industry, the median Market Cap is 146.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labo Euromedis's current Market Cap is €13.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labo Euromedis stock overvalued right now?
Based on GuruFocus' analysis, Labo Euromedis (XPAR:ALEMG) is currently considered Fairly Valued. The stock's GF Value™ is €4.48, compared to a current price of €4.88 — trading 8.9% above its estimated fair value. The current Market Cap is €13.94 Mil. Labo Euromedis' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Labo Euromedis (XPAR:ALEMG), the current Market Cap is €13.94 Mil as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labo Euromedis (XPAR:ALEMG) Overvalued in 2026?
Based on GuruFocus' analysis, Labo Euromedis stock appears to be overvalued.
The current stock price of €4.88 is trading 8.9% above its estimated GF Value™ of €4.48.
GuruFocus considers Labo Euromedis to be Fairly Valued.
Key valuation signals for XPAR:ALEMG:
Market Cap: €13.94 Mil
GF Value™: €4.48 vs. price of €4.88 (8.9% above fair value)
No single metric tells the full story. See the XPAR:ALEMG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.
61GF Score
Get the complete analysis for XPAR:ALEMG
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALEMG has been successfully added to your 
